Clinical Trial Update: The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC [Phase 2]

View source ↗

Summary

Phase II trial evaluating SHR-1210 with preoperative chemotherapy or apatinib for locally advanced esophageal squamous cell carcinoma is in Phase 2, status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• SHR-1210 (camrelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN